Dataset Information


Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.

ABSTRACT: Adeno-associated virus (AAV) gene therapy vectors have shown the best outcomes in human clinical studies for the treatment of genetic diseases such as hemophilia. However, these pivotal investigations have also identified several challenges. For example, high vector doses are often used for hepatic gene transfer, and cytotoxic T lymphocyte responses against viral capsid may occur. Therefore, achieving therapy at reduced vector doses and other strategies to reduce capsid antigen presentation are desirable.We tested several engineered AAV capsids for factor IX (FIX) expression for the treatment of hemophilia B by hepatic gene transfer. These capsids lack potential phosphorylation or ubiquitination sites, or had been generated through molecular evolution.AAV2 capsids lacking either a single lysine residue or 3 tyrosine residues directed substantially higher coagulation FIX expression in mice compared to wild-type sequence or other mutations. In hemophilia B dogs, however, expression from the tyrosine-mutant vector was merely comparable to historical data on AAV2. Evolved AAV2-LiC capsid was highly efficient in hemophilia B mice but lacked efficacy in a hemophilia B dog.Several alternative strategies for capsid modification improve the in vivo performance of AAV vectors in hepatic gene transfer for correction of hemophilia. However, capsid optimization solely in mouse liver may not predict efficacy in other species and thus is of limited translational utility.


PROVIDER: S-EPMC5412045 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5415329 | BioStudies
1000-01-01 | S-EPMC2997584 | BioStudies
1000-01-01 | S-EPMC5819605 | BioStudies
2015-01-01 | S-EPMC4326268 | BioStudies
1000-01-01 | S-EPMC2689109 | BioStudies
2017-01-01 | S-EPMC5503098 | BioStudies
2013-01-01 | S-EPMC3606062 | BioStudies
2019-01-01 | S-EPMC7496479 | BioStudies
1000-01-01 | S-EPMC5625497 | BioStudies
2013-01-01 | S-EPMC3782463 | BioStudies